Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa
Clinical trial NCT04982432 · UNKNOWN
Trial details
- NCT number
- NCT04982432
- Sponsor
- Gregor Jemec
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.